The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127537141 12753714 1 I 20110214 20160905 20160916 20160916 EXP ES-BAXTER-2016BAX046404 BAXTER 73.75 YR Y 0.00000 20160916 MD ES ES

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127537141 12753714 1 PS GENOXAL CYCLOPHOSPHAMIDE 1 Unknown COMPLETE DOSE, TREATMENT VISIT 1 Y N 12142 1275 MG POWDER FOR SOLUTION FOR INJECTION
127537141 12753714 2 SS GENOXAL CYCLOPHOSPHAMIDE 1 Unknown COMPLETE DOSE, TREATMENT VISIT 2 Y N 12142 1275 MG POWDER FOR SOLUTION FOR INJECTION
127537141 12753714 3 SS GENOXAL CYCLOPHOSPHAMIDE 1 Unknown COMPLETE DOSE, TREATMENT VISIT 3 Y N 12142 1275 MG POWDER FOR SOLUTION FOR INJECTION
127537141 12753714 4 SS GENOXAL CYCLOPHOSPHAMIDE 1 Unknown COMPLETE DOSE, TREATMENT VISIT 4 Y N 12142 1275 MG POWDER FOR SOLUTION FOR INJECTION
127537141 12753714 5 SS GENOXAL CYCLOPHOSPHAMIDE 1 Unknown COMPLETE DOSE, TREATMENT VISIT 5 Y N 12142 1275 MG POWDER FOR SOLUTION FOR INJECTION
127537141 12753714 6 SS GENOXAL CYCLOPHOSPHAMIDE 1 Unknown COMPLETE DOSE, TREATMENT VISIT 6 Y N 12142 1275 MG POWDER FOR SOLUTION FOR INJECTION
127537141 12753714 7 SS rituximab RITUXIMAB 1 Unknown COMPLETE DOSE, TREATMENT VISIT 1 Y N 0 630 MG
127537141 12753714 8 SS rituximab RITUXIMAB 1 Unknown COMPLETE DOSE, TREATMENT VISIT 2 Y N 0 630 MG
127537141 12753714 9 SS rituximab RITUXIMAB 1 Unknown COMPLETE DOSE, TREATMENT VISIT 3 Y N 0 637 MG
127537141 12753714 10 SS rituximab RITUXIMAB 1 Unknown COMPLETE DOSE, TREATMENT VISIT 4 Y N 0 850 MG
127537141 12753714 11 SS rituximab RITUXIMAB 1 Unknown COMPLETE DOSE, TREATMENT VISIT 5 Y N 0 850 MG
127537141 12753714 12 SS rituximab RITUXIMAB 1 Unknown COMPLETE DOSE, TREATMENT VISIT 6 Y N 0 850 MG
127537141 12753714 13 SS vincristine VINCRISTINE 1 Unknown COMPLETE DOSE, TREATMENT VISIT 1 Y N 0 2 MG
127537141 12753714 14 SS vincristine VINCRISTINE 1 Unknown COMPLETE DOSE, TREATMENT VISIT 2 Y N 0 2 MG
127537141 12753714 15 SS vincristine VINCRISTINE 1 Unknown COMPLETE DOSE, TREATMENT VISIT 3 Y N 0 2 MG
127537141 12753714 16 SS vincristine VINCRISTINE 1 Unknown COMPLETE DOSE, TREATMENT VISIT 4 Y N 0 2 MG
127537141 12753714 17 SS vincristine VINCRISTINE 1 Unknown COMPLETE DOSE, TREATMENT VISIT 5 Y N 0 2 MG
127537141 12753714 18 SS vincristine VINCRISTINE 1 Unknown COMPLETE DOSE, TREATMENT VISIT 6 Y N 0 2 MG
127537141 12753714 19 SS PREDNISONE. PREDNISONE 1 Unknown COMPLETE DOSE, TREATMENT VISIT 1 Y N 0 500 MG
127537141 12753714 20 SS PREDNISONE. PREDNISONE 1 Unknown COMPLETE DOSE, TREATMENT VISIT 2 Y N 0 500 MG
127537141 12753714 21 SS PREDNISONE. PREDNISONE 1 Unknown COMPLETE DOSE, TREATMENT VISIT 3 Y N 0 500 MG
127537141 12753714 22 SS PREDNISONE. PREDNISONE 1 Unknown COMPLETE DOSE, TREATMENT VISIT 4 Y N 0 500 MG
127537141 12753714 23 SS PREDNISONE. PREDNISONE 1 Unknown COMPLETE DOSE, TREATMENT VISIT 5 Y N 0 500 MG
127537141 12753714 24 SS PREDNISONE. PREDNISONE 1 Unknown COMPLETE DOSE, TREATMENT VISIT 6 Y N 0 500 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127537141 12753714 1 Chronic lymphocytic leukaemia
127537141 12753714 7 Chronic lymphocytic leukaemia
127537141 12753714 13 Chronic lymphocytic leukaemia
127537141 12753714 19 Chronic lymphocytic leukaemia

Outcome of event

Event ID CASEID OUTC COD
127537141 12753714 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127537141 12753714 Blood bilirubin decreased
127537141 12753714 Blood immunoglobulin G increased
127537141 12753714 Blood lactate dehydrogenase increased
127537141 12753714 Blood urea increased
127537141 12753714 Hypoalbuminaemia
127537141 12753714 Lymphocytosis
127537141 12753714 Neutrophil count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127537141 12753714 1 20110214 20110218 0
127537141 12753714 2 20110307 20110311 0
127537141 12753714 3 20110328 20110401 0
127537141 12753714 4 20110427 20110501 0
127537141 12753714 5 20110528 20110601 0
127537141 12753714 6 20110608 20110612 0
127537141 12753714 7 20110214 20110218 0
127537141 12753714 8 20110307 20110311 0
127537141 12753714 9 20110328 20110401 0
127537141 12753714 10 20110427 20110501 0
127537141 12753714 11 20110528 20110601 0
127537141 12753714 12 20110608 20110612 0
127537141 12753714 13 20110214 20110218 0
127537141 12753714 14 20110307 20110311 0
127537141 12753714 15 20110328 20110401 0
127537141 12753714 16 20110427 20110501 0
127537141 12753714 17 20110528 20110601 0
127537141 12753714 18 20110608 20110612 0
127537141 12753714 19 20110214 20110218 0
127537141 12753714 20 20110307 20110311 0
127537141 12753714 21 20110328 20110401 0
127537141 12753714 22 20110427 20110501 0
127537141 12753714 23 20110528 20110601 0
127537141 12753714 24 20110608 20110612 0